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Cell-cycle regulatory proteins in podocyte cell in idiopathic
nephrotic syndrome of childhood
TARAK SRIVASTAVA, ROBERT E. GAROLA, JOAN M. WHITING, and URI S. ALON
Section of Nephrology and Department of Pathology, The Children’s Mercy Hospital, University of Missouri at Kansas City,
Kansas City, Missouri

Cell-cycle regulatory proteins in podocyte cell in idiopathic
nephrotic syndrome of childhood.
Background. The podocyte cell is believed to play an important role in idiopathic nephrotic syndrome (INS) of childhood.
In adults with cellular and collapsing focal segmental glomerulosclerosis (FSGS), the expression of cell-cycle regulatory proteins such as p27, p57, and cyclin D is decreased and expression
of cyclin A, Ki-67, and p21 is observed in podocyte cells suggestive of a dysregulated podocyte phenotype. We investigated
for alterations in the expression of cyclin kinase inhibitors, p27,
p57, p21, and cyclins D and A in the podocyte cell of children
with INS.
Methods. Forty-two kidney biopsies were investigated; 14
with minimal-change disease (MCD), seven with diffuse mesangial hypercellularity (DMH), 12 with FSGS, four with Alport
syndrome (AS), and five normal biopsies. The sections were examined by immunohistochemistry using dual staining method.
Podocyte cells were first identified by Wilm’s tumor-1 staining
after which expressions of cell-cycle regulatory proteins were
analyzed. A quantitative analysis was performed for the proportion of podocyte cells that expressed each cell cycle regulatory protein.
Results. On light microscopy, all podocyte cells expressed
p27, while p57 and p21 expression was seen in a portion of
podocyte cells in normal kidney biopsies. Cyclin D was expressed in a small percent of podocyte cells though the expression was more marked in mesangial and endothelial cells.
Cyclin A expression was not seen in normal biopsies. The mean
expression of p27 decreased significantly in order from normal
(100%), MCD (45.9%), DMH (22.4%), and FSGS (16.7%),
and the difference between MCD and FSGS was significant.
p21 was significantly and equally reduced in MCD (2.3%),
DMH (0%), and FSGS (0.7%) compared to normal (66.6%).
There was no significant difference in expression of p57, cyclin
D and cyclin A in the podocyte cells between normal and
children with INS. Children with AS showed a significant decrease in p27 and p21 expression, while the expression of p57,
cyclin D and cyclin A were unchanged from normal, thus demonstrating a pattern similar to INS.
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Conclusion. The podocyte cell in children with INS downregulates expression of cyclin kinase inhibitors such as p21 and
p27, but not p57, but does not up-regulate cyclin D and cyclin
A that are needed to overcome the G1/S transition and move
the cell forward in the cell cycle process. Thus, the podocyte cell
remains trapped in the G1 arrest phase. In children with INS
or AS, the dysregulated podocyte phenotype is different than
the one described in adults with cellular or collapsing FSGS.

Idiopathic nephrotic syndrome of childhood (INS) is
a common renal disease in children. On biopsy, the common histologies of INS include minimal-change disease
(MCD), diffuse mesangial hypercellularity (DMH), and focal segmental glomerulosclerosis (FSGS), which together
constitute ⬃90% of childhood INS [1]. MCD is characterized by minimal changes in the glomerulus, responds
well to steroid treatment, and rarely progresses to renal
failure. On the other end of the spectrum, FSGS is characterized by segmental glomerular hyalinosis and sclerosis, responds poorly to steroid treatment, and frequently
progresses to renal failure [2]. The clinical course of
DMH lies between MCD and FSGS. The visceral glomerular epithelial cell or podocyte cell plays an important role in glomerular ultrafiltration, glomerular basement membrane turnover, support for the glomerular
capillary tuft, and formation of urine [3]. The podocyte
cell demonstrates significant alteration, such as effacement of foot processes, apical displacement of slit diaphragms, and detachment of the podocyte from the glomerular basement membrane in INS [4–6]. In experimental
animals, Laurens et al [7, 8] have reproduced INS by
isolated injury to the podocyte. We found synaptopodin,
a podocyte protein, to decline with increasing severity
of INS, manifested by a decrease in synaptopodin expression from MCD to DMH to FSGS [9]. We also showed
other podocyte proteins, such as GLEPP-1 and nephrin,
to be decreased in INS [10]. It thus seems that in the
event of podocyte dysfunction/ injury, it clinically manifests as proteinuria, and at the molecular level podocyte
proteins such as synaptopodin, GLEPP-1, and nephrin
become disorganized.
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The cell-cycle process is a highly organized process
that allows the cell to proliferate under both physiologic
and pathologic conditions. The process ensures that DNA
replication occurs only once and that the DNA replication is completed before mitosis occurs in each cycle
[11–15]. This highly organized cell-cycle process is regulated by a number of cell-cycle regulatory proteins: (1)
positive cell-cycle regulatory proteins, such as “cyclins”
and “cyclin-dependent kinase (CDK),” which aid in the
progression and completion of the cell cycle; and (2)
negative cell-cycle regulatory proteins, “cyclin kinase inhibitors (CKI),” which inhibit the cell-cycle process. Cells
can also exit from the cell cycle at any phase by undergoing apoptosis (death of cell), senescence (permanently
growth-arrested cells), terminally committed specialized
cells (cells can proliferate under appropriate stimuli), or
be uncontrolled as in neoplasia [13]. Mature podocyte
cells in the glomerulus are regarded as growth-arrested
cells that normally express negative cell-cycle regulatory
proteins p27 and p57 and positive cell-cycle regulatory
proteins cyclin D, but not cyclin A, cyclin B1, or Ki-67
[16]. In adult subjects with cellular and collapsing variant
of FSGS and HIV-associated nephropathy (HIVAN),
Shankland et al [17] found decreased p27 and p57 expression and de novo expression for p21 in podocyte cells.
Barisoni et al [18] reported a decrease in p27, p57, and
cyclin D1 expression with expression for cyclin A and
Ki-67 in podocyte cells in collapsing glomerulopathies.
On the other hand, Nagata et al [19] showed that the
proliferating epithelial cells in FSGS are not podocyte
cells but parietal epithelial cells.
The podocyte is a unique glomerular cell because its
growth response to injury differs from the mesangial or
endothelial cell by virtue of its apparent inability to proliferate [13]. The podocyte cell plays an important role in
progressive glomerulosclerosis and subsequent chronic
renal failure [20–23]. In childhood INS, the injury to the
podocyte cell is an acquired immunologic injury, whereas
in Alport syndrome (AS) the podocyte injury is subsequent to a genetic mutation in ␣-5 of collagen type IV
of the glomerular basement membrane [24]. We studied
the cell cycle regulatory protein such as p27, p57, p21,
cyclin D, and cyclin A expression in podocytes in both
INS and AS to answer the question as to whether the alterations in protein expression is a generalized response
to podocyte injury or whether it is exclusive to INS.
METHODS
Kidney biopsies from children with INS were included
in the study only if the histology was consistent with MCD,
DMH, or FSGS as described by the International Study
of Kidney Disease in Children (ISKDC) [25] and the tissue in the archived paraffin block had at least five nonsclerosed glomeruli. Control tissue (normal) was obtained
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from children who had normal renal biopsy following
evaluation of loin pain-hematuria syndrome. A total of 42
kidney biopsies were investigated: 14 with MCD, seven
with DMH, 12 with FSGS, four with AS, and five whose
biopsies were normal. The age at the time of biopsy was
noted. Serial 3 m sections were obtained from the cases
listed above, air-dried, and heat fixed on slides. The
sections were deparaffinized with xylene and iodine and
rehydrated in graded series of alcohol. The sections were
treated with Target Retrieval Solution (Dako #S1700,
Dako Corp., Carpinteria, CA, USA) in a steamer at 90⬚C
to 95⬚C for 20 minutes and then cooled for 15 minutes.
The endogenous avidin and biotin activity was blocked
by egg white and skimmed milk as described by Miller
et al [26]. The sections were examined by immunohistochemistry using dual staining method. Podocyte cells were
identified in the biopsy by Wilm’s tumor-1 (WT-1) staining as it is exclusively expressed in the podocyte cells in
the glomerulus [27]. Antihuman WT-1, a mouse monoclonal antibody (Dako Corp.) was used in 1:100 dilution
for WT-1 staining. The Universal Dako’s LSAB ⫹ immunostaining system with streptavidin-biotin conjugated to
alkaline phosphatase was used for the immunohistochemical reaction. Vector red (Vector Laboratories, Inc.,
Burlingame, CA, USA) was used as the chromogen, which
stained WT-1 antigen red. The cell-cycle regulatory proteins used in the study were as follows: (1) p27 staining was performed with a mouse monoclonal antibody
(sc-1641; Santa Cruz Biotechnology, Inc., Santa Cruz,
CA, USA) at 1:50 dilution, (2) p21 staining with a mouse
monoclonal antibody (sc-817; Santa Cruz Biotechnology
Inc.) at 1:100 dilution, (3) p57 staining with a goat polyclonal antibody (sc-1040G; Santa Cruz Biotechnology
Inc.) at 1:50 dilution, (4) cyclin D1 staining with a mouse
monoclonal antibody (sc-8396; Santa Cruz Biotechnology Inc.) at 1:50 dilution, and (5) cyclin A staining with
a rabbit polyclonal antibody (sc-751; Santa Cruz Biotechnology Inc.) at 1:100 dilution. The Universal Dako’s
LSAB ⫹ immunostaining system with streptavidin-biotin conjugated to horseradish peroxidase was used in the
immunohistochemical reaction for cell-cycle regulatory
proteins. Diaminobenzidine with 3% cobalt was used as
the chromogen, which gave a brown-black color to cellcycle antigen. In addition, a negative control using an
irrelevant antibody, a positive control for single WT-1
immunohistochemical reaction, a positive control for single cell-cycle regulatory protein immunohistochemical
reaction and a positive control for dual WT-1 and cellcycle regulatory protein immunohistochemical reaction
were also performed. For control immunohistochemical
reactions, a control kidney tissue was used for p27, p57,
and cyclin D, and a lymphoma tissue was used for p21
and cyclin A. In addition to the above controls for the
experiment, positive expression of cell-cycle regulatory
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Table 1. Expression of p27, p21, p57, and cyclin D in podocyte cells of children with idiopathic nephrotic syndrome (INS).
The results are expressed as mean ⫾ SD
Percent-positive glomeruli

p27
Normal vs. (P value)
MCD vs. (P value)
p21
Normal vs. (P value)
MCD vs. (P value)
p57
Normal vs. (P value)
MCD vs. (P value)
Cyclin D
Normal vs. (P value)
MCD vs. (P value)

Percent-positive podocyte

Normal
(N ⫽ 5)

MCD
(N ⫽ 14)

DMH
(N ⫽ 7)

FSGS
(N ⫽ 12)

Normal
(N ⫽ 5)

100.0 ⫾ 0.0
—

66.9 ⫾ 39.5
0.291
—
9.2 ⫾ 15.2
⬍0.001
—
99.1 ⫾ 2.0
0.999
—
8.4 ⫾ 14.9
0.097
—

45.6 ⫾ 37.4
0.058
0.565
0.0 ⫾ 0.0
⬍0.001
0.222
86.3 ⫾ 24.9
0.243
0.095
8.2 ⫾ 11.7
0.147
0.999

39.7 ⫾ 35.3
0.015
0.224
2.8 ⫾ 6.7
⬍0.001
0.396
96.4 ⫾ 7.1
0.945
0.931
0.0 ⫾ 0.0
0.005
0.243

100.0 ⫾ 0.0
—

100.0 ⫾ 0.0
—
100.0 ⫾ 0.0
—
23.4 ⫾ 11.1
—

66.6 ⫾ 12.5
—
60.6 ⫾ 7.0
—
3.1 ⫾ 2.8
—

MCD
(N ⫽ 14)
45.9 ⫾ 31.5
0.001
—
2.3 ⫾ 4.3
⬍0.001
—
44.7 ⫾ 18.7
0.351
—
1.6 ⫾ 3.7
0.752
—

DMH
(N ⫽ 7)
22.4 ⫾ 28.0
⬍0.001
0.203
0.0 ⫾ 0.0
⬍0.001
0.557
37.0 ⫾ 21.5
0.138
0.795
0.7 ⫾ 1.0
0.452
0.852

FSGS
(N ⫽ 12)
16.7 ⫾ 18.9
⬍0.001
0.028
0.7 ⫾ 1.7
⬍0.001
0.686
45.0 ⫾ 18.2
0.385
0.999
0.0 ⫾ 0.0
0.171
0.359

Abbreviations are: MCD, minimal change disease; DMH, diffuse mesangial hypercellularity; and FSGS, focal segmental glomerulosclerosis.

protein in tubular cells acted as controls within each
section.
Kidney biopsies stained for WT-1 and one of the cellcycle regulatory proteins were first examined by light
microscopy. On light microscopy, evaluation of each glomerulus was done for cells expressing WT-1 and cellcycle regulatory protein (i.e., podocyte cell expressing
the protein under study), WT-1 protein only (i.e., podocyte cell not expressing the protein under study), and
only cell-cycle regulatory protein but not WT-1 (nonpodocyte glomerular cell expressing the protein under
study). Following an initial qualitative assessment, a
quantitative analysis for cell-cycle regulatory protein expression was performed. First, the percent of glomeruli
that stained positive for the cell-cycle regulatory protein
in the biopsy section was obtained. Next, in glomeruli
that stained positive for cell-cycle regulatory protein,
the percent of podocyte cells that express the cell cycle
regulatory protein was obtained. The product of the above
two values gave the proportion of total podocyte cells
that expressed the cell-cycle regulatory protein. To compare cell-cycle regulatory protein expression and age
among the four groups of normal, MCD, DMH, and FSGS
children, univariate analysis of variance (ANOVA) followed by Tukey HSD test was used. Student t test was
used to compare normal with AS.
RESULTS
The mean ⫾ SD for age in years for normal (9.7 ⫾
4.0) was not different from MCD (5.4 ⫾ 3.2, P ⫽ 0.13),
DMH (5.3 ⫾ 3.6, P ⫽ 0.18), FSGS (9.1 ⫾ 4.0, P ⫽ 0.98),
or AS (10.4 ⫾ 2.2, P ⫽ 0.78). The age difference among
children with INS (MCD, DMH, and FSGS) was not
statistically different either. The biopsies were performed for associated hematuria in seven (21.2%), for
steroid sensitive frequently relapsing/ steroid dependent

nephrotic syndrome in 14 (42.4%) and for steroid-resistant nephrotic syndrome in 12 (36.4%). The subjects
included 19 boys and 14 girls. There were 27 Caucasian,
four African-American, and two Asian children in the
study. Sixteen children went into remission with steroid
therapy with/ without an 8-week course of cyclophosphamide, while the other 17 children were either steroidresistant or steroid-dependent needing additional immunosuppressive therapy. The total podocyte cell count per
glomerulus for normal children (24.0 ⫾ 2.5) was not
different from MCD (19.6 ⫾ 3.2, P ⫽ 0.47), DMH (23.2 ⫾
10.1, P ⫽ 0.99), FSGS (17.3 ⫾ 3.6, P ⫽ 0.13), or AS
(18.1 ⫾ 4.9, P ⫽ 0.42).
Normal and INS
On light microscopy, all podocyte cells in all glomeruli
expressed p27 protein in normal children. The percent
of positive glomeruli and podocyte cells expressing p27
decreased in children with INS; the expression decreasing in order from normal to MCD to DMH to FSGS
(Table 1 and Fig. 1). The decrease in p27 expression in
podocyte cells reached statistical difference between
normal and MCD, DMH and FSGS (Table 1). The decrease was significantly more marked in FSGS compared
to MCD (Table 1). In normal children, podocyte cells
expressing p21 was observed in all glomeruli. In a given
glomerulus not all podocyte cells expressed p21 (Table 1
and Fig. 1). The percent of positive glomeruli and positive podocyte cells expressing p21 were markedly reduced in children with INS (Table 1 and Fig. 1). The
decrease in percent positive glomeruli and podocyte cells
for p21 expression reached statistical difference between
normal and MCD, DMH, and FSGS (Table 1). There
was no difference within the INS group of MCD, DMH,
and FSGS (Table 1). In normal children, all glomeruli
had podocyte cells that expressed p57 protein but like
p21 not all podocyte cells in the glomeruli expressed p57
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Fig. 1. Photomicrograph shows the expression of p27, p21, p57, cyclin D, and cyclin A in podocyte cells of normal and children with minimal
change disease (MCD), diffuse mesangial hypercellularity (DMH), and focal segmental glomerulosclerosis (FSGS) in kidney tissue. The podocyte
cell is identified by Wilm’s tumor (WT-1) expression (stained red with Vector red) and the cell-cycle regulatory protein is stained brown-black
with diaminobenzidine with 3% cobalt. Only podocyte cells that showed homogenous and intense expression of cell cycle regulatory protein above
the background were accepted as positive expression. The expression for p27 decreased in order from normal to MCD to DMH to FSGS. p21
expression was markedly decreased in children with MCD, DMH, or FSGS compared to normal. The expression for p57 remained unchanged
between normal, MCD, DMH, and FSGS. Cyclin D expression was similar between normal, MCD, DMH, and FSGS. Cyclin A expression was
not observed in either normal, MCD, DMH, or FSGS.

(Table 1 and Fig. 1). There was no difference in percent
of positive glomeruli or percent positive podocyte cells
expressing p57 in normal and children with INS and
within the INS group of MCD, DMH, and FSGS (Table 1). On light microscopy, cyclin D was predominantly
observed in endothelial and mesangial cells in the glomeruli although a small percentage of glomeruli and
podocyte cells did express cyclin D in normal children
(Table 1 and Fig. 1). There was no difference in cyclin

D expression in normal and children with INS and within
the INS group of MCD, DMH, and FSGS (Table 1).
On light microscopy, cyclin A was not expressed in the
podocyte cells of either normal children or children with
INS (Fig. 1).
Normal and AS
The podocyte expression of p27 and p21 was significantly decreased in children with AS (p27, 63.5 ⫾ 17.0;
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p21, 18.9 ⫾ 13.5) when compared with normal children
(p27, 100 ⫾ 0.0, P ⫽ 0.04; p21, 66.6 ⫾ 12.5, P ⫽ 0.01).
There was no difference in podocyte expression of p57
and cyclin D between normal children (p57, 60.6 ⫾ 7.0;
cyclin D, 3.1 ⫾ 2.8) and AS (p57, 58.4 ⫾ 10.4, P ⫽ 0.68;
cyclin D, 6.3 ⫾ 1.5, P ⫽ 0.14). Cyclin A was not expressed
in the podocyte cells of either normal or children with
AS. The pattern of changes observed in AS biopsies was
thus similar to those with INS.
DISCUSSION
In recent times, cell-cycle regulatory proteins have
become an area of intense research in order to understand the changes that occur in various renal diseases.
The roles of these proteins in renal diseases have been
addressed in several reviews [11–15]. Our earlier work on
podocyte cells in childhood INS indicated that podocyte
dysfunction/ injury is clinically manifested as proteinuria,
while at the molecular level, podocyte proteins such as
synaptopodin, GLEPP-1, and nephrin become disorganized [9, 10]. Thus, we believe that understanding the
podocyte’s response following injury is critical to our
understanding of the pathophysiology of INS. In adult
subjects with cellular and collapsing variants of FSGS
and HIVAN, the podocyte cells were observed to have
decreased p27, p57, and cyclin D expression and positive
staining for p21, cyclin A, and Ki-67 suggestive of a dysregulated podocyte phenotype [17, 18]. In contrast, Nagata et al [19] has contested that the proliferating epithelial cells in FSGS are not podocyte cells but parietal
epithelial cells. These observations led us to investigate
for alterations in expression of cell-cycle regulatory proteins in podocyte cells in children with INS. To overcome
the issue of podocyte cell versus parietal epithelial cell,
we identified the podocyte cell by WT-1 expression,
based on Mundlos et al [27] observation that WT-1 protein is exclusively expressed in podocyte cells. In our
earlier study using the same biopsy material, we had shown
normal WT-1 expression in podocyte cells of children
with INS [9]. This technique allows study of the cellcycle regulatory proteins expressed solely in podocytes
excluding other resident cells of the glomerulus.
p27 is believed to play a role in differentiation of cells,
maintain podocyte cells in quiescence by cell cycle arrest
in G1 phase, and modulate apoptosis and cell-cycle exit
response to antimitogenic cues [16, 28]. In p27 knockout
mice, the kidneys are 25% larger due to a proportionate
increase in all resident cell types, no renal histologic
changes are observed by light or electron microscopy,
and renal function is normal [29–32]. In animal models
of glomerulonephritis, the changes in p27 are variable,
it is decreased in Thy-1 model, and increased in passive
Heymann nephritis [33, 34]. Although the complete absence of p27 does not have an impact on renal develop-

ment or function, it does get up- or down-regulated in
response to an exogenous insult. In adults, p27 is reported
to be decreased in cellular and collapsing variant of
FSGS and HIVAN, but unchanged in MCD [17]. In our
study we observed a significant decrease in p27 expression in podocyte cells in children with INS, decreasing
in order from normal to MCD to DMH to FSGS. The
decrease in p27 expression observed in our study is proportional to the severity of the injury. Unlike Shankland
et al [17], we found a difference between MCD and normal, which could be attributed to a quantitative assessment performed by us rather than a qualitative assessment
for p27 expression.
Could the observed difference in p27 expression between INS and normal children be due to loss of podocyte cells from the glomerulus or be age-related? Loss
of podocytes from the glomerulus cannot explain the
decrease in p27 expression, as unlike children with inflammatory glomerulonephritis, loss of podocytes in the
urine is not observed in children with MCD [35]. The
total podocyte count per glomerulus was not different
among the four groups. WT-1 and p57 are expressed
only in the podocyte cells of the glomerulus [27, 36]. The
normal expression of WT-1 as observed in our earlier
study and p57 in this study, in both normal and children
with INS supports the fact that the observations are not
related to loss of podocyte cells [9]. There was no significant difference between the ages of children with MCD,
DMH, FSGS, and normal children. Thus, the changes
observed in p27 expression could not be attributed to
the age of the patient.
The p21 protein is thought to play an important role
at the G1 checkpoint [37]. In our study we observed p21
expression in normal kidney unlike Shankland et al [17]
who had not detected p21 in normal tissue, and a significant decrease in p21 expression in podocyte cells in
children with INS. The p21 CKI is rapidly induced in response to physiologic and chemical inducers of differentiation and p21 gene is a candidate gene linking differentiation signals to G1 arrest in multiple cell lines [38]. The
p21 expression is believed to be regulated by both a p53
dependent and a p53 independent pathway [38]. Englert
et al [39] have shown that WT-1 gene induces an increase
expression of p21 mRNA independent of p53, and in the
kidney p21 is expressed in the differentiating glomerular
podocytes along with WT-1, which, in turn, may contribute to WT-1–dependent differentiation pathways in the
kidney. Englert et al [39] study suggests a close functional
relationship between WT-1 and p21. WT-1 and p21 play
an important role for cell differentiation and G1 cell arrest. The podocyte cell is characterized by arrest in G1
phase and abundant expression of WT-1. Thus, our finding of p21 in podocytes in normal kidney unlike Shankland et al [17] was not an unexpected observation based
on earlier studies showing close functional relationship
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between WT-1 and p21 in cell differentiation and G1
cell arrest. We could speculate that difference in p21
expression between Shankland study [17] and ours could
be related to the epitope recognition site of the antibody
used in the two studies. The antibody used by us was
clone 187, produced by immunization with full-length
p21 of human origin. The antibody used by Shankland
et al [17] was from clone SX 118, which is raised against
a purified recombinant human p21-glutathione-S-transferase (GST) fusion protein and only recognizes the proliferating cell nuclear antigen (PCNA)–binding domain
of p21. It is possible that our antibody recognizes an
epitope of p21 different from the PCNA binding site as
we found consistent results with normal kidney tissue
from children with Wilm’s tumor (data not shown) and
abnormal tissue from children with congenital nephrotic
syndrome of Finnish type (data not shown).
p57 is believed to play a role in the terminal differentiation of podocyte cell and overexpression of p57 arrests
the cell in G1 phase [40, 41]. The p57 knockout mice
develop noncystic medullary dysplasia in the kidneys
and have many features that resemble Beckwith-Weidermann syndrome [36]. Although p57 was reported decreased in cellular and collapsing variant of FSGS, we did
not observe any difference in p57 expression in podocyte
cells in normal and children with INS [17, 18]. The cellular and collapsing variant of FSGS is a small subset of
FSGS in adults [42]. In our own series of 34 children
with FSGS from 1984 to 1995 seen at our institution, we
did not find a single child with cellular or collapsing
variant of FSGS, which is a rare entity in children [1]. In
the present study, children had classic FSGS. Currently,
there are no studies available either in adults or children
with podocyte expression of p57 in subjects with classic
FSGS to make a suitable comparison. The dysregulated
podocyte phenotype as described in adults for the subset
of cellular and collapsing FSGS was not observed in
children with classic FSGS. Yang, Gubler, and Beaufils
[43] using other proliferation and podocyte markers
found an abnormal distribution of WT-1 and PAX-2, and
extensive loss of podocyte markers in idiopathic collapsing glomerulopathy and HIVAN; this dysregulation was
associated with podocyte proliferation without detectable apoptosis, while in FSGS, proliferation was not observed, which indirectly supports our finding of absence
of a proliferative podocyte phenotype in childhood INS.
In addition, Nagata et al [19] have suggested that the
hyperplastic cell in FSGS is the parietal epithelial cell
and not podocyte cell. Thus, the above studies, combined
with our own study would suggest that the subset of
collapsing and cellular FSGS and HIVAN may have a
different pathogenic pathway from INS, where proliferation is absent. The absence of proliferative dysregulated
podocyte phenotype in childhood INS is further supported by our data on cyclin D and cyclin A (vide infra).
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Cyclin D is required for cell proliferation and G1/S
transition and works through inactivation the retinoblastoma protein [13]. In Thy-1 and passive Heymann nephritis models of glomerulonephritis, cyclin D is unchanged
[33, 34]. In our study, we did not observe any difference
in cyclin D expression in podocyte cells in normal and
children with INS, which is consistent with animal data,
but stands in contrast to Barisoni et al [18] who found
cyclin D to be decreased in collapsing FSGS. We found
cyclin D to be predominantly expressed in the endothelial and mesangial cells of the glomerulus. Cyclin A increase in late G1, and peaks in S and G2 phase, and is
required for onset of DNA synthesis and to overcome
G1/S block [13]. In our study, we did not observe any
expression in cyclin A in podocyte cells in normal and
children with INS. The difference in our observation
from Barisoni et al [18] is discussed above.
Children with AS had similar changes in cell-cycle
regulatory proteins as those with INS, with decrease in
p27 and p21 expression, unchanged expression of p57
and cyclin D, and absent cyclin A. Thus, it appears that
the changes observed following an acquired immunologic injury to podocyte cell in children with INS are
similar to the changes observed in AS, which results
from a genetic mutation in ␣5 of collagen type IV of the
glomerular basement membrane. In our earlier studies
we had found the expression of synaptopodin, GLEPP-1,
and nephrin to be decreased in both children with INS
(acquired immunologic injury to podocyte cell) and children with Galloway-Mowat syndrome and congenital
nephrotic syndrome of the Finnish type (podocyte dysfunction following genetic mutations) [9, 10]. Thus, the
changes in the cell-cycle regulatory proteins observed
by us might indicate a final common pathway to different
injury processes to the podocyte cell.
There was no statistical difference between expression
of podocyte cell-cycle regulatory proteins and clinical
response to steroids, nor was there statistical difference
in expression of cell-cycle regulatory proteins between
Caucasian and African American children (data not
shown). Only four children in our series had either elevated serum creatinine or had progressed to end stage
renal failure, hence we did not correlate cell-cycle regulatory protein expression and renal outcome as the sample
size was too small. The study was limited, as children with
mild MCD are not routinely biopsied; thus, our MCD
group was skewed toward moderate to severe MCD. We
can cautiously speculate that inclusion of mild MCD
cases would not have altered our results much, as the
difference between normal and MCD showed a dichotomous pattern in which either marked difference exists,
as in the case of p21 and p27, or no difference is seen
as in the case of p57, cyclin D, and cyclin A.
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CONCLUSION
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In our study we observed CKIs p27, p57, and p21 to
be present in normal kidneys, which keep the podocyte
cell differentiated and in G1 arrest. We found that in
children with INS, the podocyte cell down-regulates expression of CKIs such as p21 and p27 but not p57, and
fails to up-regulate cyclin D and cyclin A (marker of “S”
and “G2” phase), which are needed to overcome the G1/S
transition and move the cell forward in the cell-cycle
process. This results in the podocyte cell remaining
trapped in the G1 arrest phase. The observed changes
in cell-cycle regulatory proteins were observed in both
children with INS and AS. In adults with cellular and
collapsing variant of FSGS and HIVAN, alterations have
been observed in p27, p57, p21, cyclin D, and cyclin A
expression in the podocyte cell, which suggests a dysregulated phenotype that is more dedifferentiated and immature and permissive for podocyte proliferation [17, 18].
We did not observe the proliferative dysregulated podocyte phenotype in children with INS as described in the
above adult studies for cellular and collapsing variant of
FSGS and HIVAN. Yang, Gubler, nd Beaufils [43] and
our study would suggest that the subset of collapsing
and cellular FSGS may have a different pathogenic pathway with proliferation as an important feature in the
podocyte cell unlike childhood INS or AS where proliferation is absent in the podocyte. An injured cell as a response to injury can either undergo proliferation and /or
hypertrophy. Our data suggest that the podocyte cell in
INS does not respond with proliferation as suggested by
earlier studies. The current study does not allow us to
infer for cellular hypertrophy. The most important aspect
of this study is that it provides us with an insight into
the changes that are occurring in the cellular machinery
of podocyte cell in INS. Our data are the first report
on the changes that occur in the cell-cycle regulatory
proteins in podocyte cells of children with INS. It, thus,
seems that more studies are needed with special attention to cell hypertrophy markers to appreciate the role
of cell-cycle regulatory proteins in the podocyte in both
adult and childhood nephrotic syndrome.

1. Srivastava T, Simon SD, Alon US: High incidence of focal segmental glomerulosclerosis in nephrotic syndrome of childhood.
Pediatr Nephrol 13:13–18, 1999
2. Barratt TM, Clark G: Minimal change nephrotic syndrome and
focal segmental glomerulosclerosis, in Pediatric Nephrology, edited
by Holliday MA, Barratt TM, Avner ED, 3rd ed, Baltimore,
Williams and Wilkins, 1994, pp 767–787
3. Mundel P, Kriz W: Structure and function of podocytes: an update. Anat Embryol 192:385–397, 1995
4. Kanwar YS, Rosenzweig LJ: Altered glomerular permeability as
a result of focal detachment of the visceral epithelium. Kidney Int
21:565–574, 1982
5. Whiteside C, Prutis K, Cameron R, Thompson J: Glomerular
epithelial detachment, not reduced charge density, correlates with
proteinuria in adriamycin and puromycin nephrosis. Lab Invest
61:650–660, 1989
6. Messina A, Davies DJ, Dillane PC, Ryan GB: Glomerular epithelial abnormalities associated with the onset of proteinuria in
aminonucleoside nephrosis. Am J Pathol 126:220–229, 1987
7. Laurens W, Battaglia C, Foglieni C, et al: Direct podocyte damage in the single nephron leads to albuminuria in vivo. Kidney Int
47:1078–1086, 1995
8. Laurens WE, Vanrenterghem YF, Steels PS, van Damme BJ:
A new single nephron model of focal and segmental glomerulosclerosis in the Munich-Wistar rat. Kidney Int 45:143–149, 1994
9. Srivastava T, Garola RE, Whiting JM, Alon US: Synaptopodin
expression in idiopathic nephrotic syndrome of childhood. Kidney
Int 59:118–125, 2001
10. Srivastava T, Whiting JM, Garola RE, et al: Podocyte proteins
in Galloway-Mowat syndrome. Pediatr Nephrol 16:1022–1029, 2001
11. Terada Y, Inoshita S, Nakashima O, et al: Cyclins and the cyclinkinase system–Their potential roles in nephrology. Nephrol Dial
Transplant 13:1913–1916, 1998
12. Shankland SJ: Cell cycle regulatory proteins in glomerular disease. Kidney Int 56:1208–1215, 1999
13. Shankland SJ: Cell-cycle control and renal disease. Kidney Int
52:294–308, 1997
14. Schocklmann HO, Lang S, Sterzel RB: Regulation of mesangial
cell proliferation. Kidney Int 56:1199–1207, 1999
15. Preisig P: A cell cycle-dependent mechanism of renal tubule epithelial cell hypertrophy. Kidney Int 56:1193–1198, 1999
16. Nagata M, Nakayama K, Terada Y, et al: Cell cycle regulation
and differentiation in the human podocyte lineage. Am J Pathol
153:1511–1520, 1998
17. Shankland SJ, Eitner F, Hudkins KL, et al: Differential expression of cyclin-dependent kinase inhibitors in human glomerular
disease: Role in podocyte proliferation and maturation. Kidney
Int 58:674–683, 2000
18. Barisoni L, Mokrzycki M, Sablay L, et al: Podocyte cell cycle
regulation and proiferation in collapsing glomerulopathies. Kidney
Int 58:137–143, 2000
19. Nagata M, Horita S, Shu Y, et al: Phenotypic characteristics
and cyclin-dependent kinase inhibitors repression in hyperplastic
epithelial pathology in idiopathic focal segmental glomerulosclerosis. Lab Invest 80:869–880, 2000
20. Nagata M, Kriz W: Glomerular damage after uninephrectomy in
young rats. II. Mechanical stress on podocytes as a pathway to
sclerosis. Kidney Int 42:148–160, 1992
21. Kihara I, Yatoita E, Kawasaki K, Yamamoto T: Limitations of
podocyte adaptation for glomerular injury in puromycin aminonucleoside nephrosis. Pathol Int 45:625–634, 1995
22. Fries JW, Sandstrom DJ, Meyer TW, Rennke HG: Glomerular
hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat. Lab Invest 60:205–218, 1989
23. Kriz W, Elger M, Nagata M, et al: The role of podocytes in the
development of glomerular sclerosis. Kidney Int 45 (Suppl 45):
S64–S72, 1994
24. Gubler MC, Knebelmann B, Antignac C: Inherited glomerular
disease, in Pediatric Nephrology, edited by Barratt TM, Avner
ED, Harmon WE, 4th ed, Baltimore, Lippincott Williams and Wilkins, 1999, pp 475–495

ACKNOWLEDGMENTS
This work was supported by grant from “Katharine B. Richardson
Associates Endowment Fund” (# 01.4884) and The Sam and Helen
Kaplan Research Fund in Pediatric Nephrology. We thank Stephen D.
Simon, Ph.D., from the Department of Medical Research at Children’s
Mercy Hospital, for his assistance in the statistical analysis. The study
was approved by the Institutional Review Board #E 00 00-06.
Reprint requests to Tarak Srivastava, M.D., Section of Nephrology,
The Children’s Mercy Hospital, 2401Gillham Road, Kansas City, MO
64108.
E-mail: tsrivastava@cmh.edu

Srivastava et al: Cell-cycle proteins in nephrotic syndrome
25. Churg J, Habib R, White RH: Pathology of the nephrotic syndrome in children: A report for the International Study of Kidney
Disease in Children. Lancet 760:1299–1302, 1970
26. Miller RT, Kubier P, Reynolds P, et al: Blocking of endogenous
avidin-binding activity in immunohistochemistry. Appl Immunohistochem Mol Morphol 7:63–65, 1999
27. Mundlos S, Pelletier J, Darveau A, et al: Nuclear localization
of the protein encoded by the Wilms’ tumor gene WT1 in embryonic and adult tissues. Development 119:1329–1341, 1993
28. Hiromura K, Pippin JW, Fero ML, et al: Modulation of apoptosis
by the cyclin-dependent kinase inhibitor p27(Kip1). J Clin Invest
103:597–604, 1999
29. Ophascharoensuk V, Fero ML, Hughes J, et al: The cyclin-dependent kinase inhibitor p27Kip1 safeguards against inflammatory
injury. Nat Med 4:575–580, 1998
30. Fero ML, Rivkin M, Tasch M, et al: A syndrome of multiorgan
hyperplasia with features of gigantism, tumorigenesis, and female
sterility in p27(Kip1)-deficient mice. Cell 85:733–744, 1996
31. Nakayama K, Ishida N, Shirane M, et al: Mice lacking p27(Kip1)
display increased body size, multiple organ hyperplasia, retinal
dysplasia, and pituitary tumors. Cell 85:707–720, 1996
32. Kiyokawa H, Kineman RD, Manova-Todorova KO, et al: Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85:721–732, 1996
33. Shankland SJ, Floege J, Thomas SE, et al: Cyclin kinase inhibitors
are increased during experimental membranous nephropathy: Potential role in limiting glomerular epithelial cell proliferation in
vivo. Kidney Int 52:404–413, 1997

1381

34. Shankland SJ, Hugo C, Coats SR, et al: Changes in cell-cycle
protein expression during experimental mesangial proliferative
glomerulonephritis. Kidney Int 50:1230–1239, 1996
35. Hara M, Yanagihara T, Takada T, et al: Urinary excretion of
podocytes reflects disease activity in children with glomerulonephritis. Am J Nephrol 18:35–41, 1998
36. Zhang P, Liegeois NJ, Wong C, et al: Altered cell differentiation
and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature 387:151–158, 1997
37. Deng C, Zhang P, Harper JW, et al: Mice lacking p21CIP1/WAF1
undergo normal development, but are defective in G1 checkpoint
control. Cell 82:675–684, 1995
38. Steinman RA, Hoffman B, Iro A, et al: Induction of p21 (WAF-1/
CIP1) during differentiation. Oncogene 9:3389–3396, 1994
39. Englert C, Maheswaran S, Garvin AJ, et al: Induction of p21
by the Wilms’ tumor suppressor gene WT1. Cancer Res 57:1429–
1434, 1997
40. Lee MH, Reynisdottir I, Massague J: Cloning of p57KIP2, a
cyclin-dependent kinase inhibitor with unique domain structure
and tissue distribution. Genes Dev 9:639–649, 1995
41. Matsuoka S, Edwards MC, Bai C, et al: p57KIP2, a structurally
distinct member of the p21CIP1 Cdk inhibitor family, is a candidate
tumor suppressor gene. Genes Dev 9:650–662, 1995
42. D’Agati V: The many masks of focal segmental glomerulosclerosis.
Kidney Int 46:1223–1241, 1994
43. Yang Y, Gubler MC, Beaufils H: Dysregulation of podocyte
phenotype in idiopathic collapsing glomerulopathy and HIV-associated nephropathy. Nephron 91:416–423, 2002

